Advocates express concern over HHS plans to address overprescribing, warning of misinformation's impact on mental health treatment.
Leading associations in mental health are expressing great concern over the U.S. Department of Health and Human Services' (HHS's) planned actions targeting overprescribing of psychiatric medication. Advocates fear that absent a full accounting of the research evidence supporting medication treatments, misinformation will dissuade individuals from pursuing needed mental health treatment.
No takes yet. Share an insight, caveat, or question.
Gary Enos (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: